Showing results (391-400 of 415) with videos related to

Sort By:
Pageof 42
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2016
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on MortalityLaura J Rojas, Madiha Salim, Eric Cober, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 22, 2023
A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patientsPatrick O Hanafin, Andrea Kwa, Alexandre P Zavascki, et al.
Antimicrobial Agents and Chemotherapy|May 7, 2014
Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional networkDavid van Duin, Federico Perez, Susan D Rudin, et al.
Infection Control and Hospital Epidemiology|August 7, 2013
Prevalence and risk factors associated with vancomycin-resistant Staphylococcus aureus precursor organism colonization among patients with chronic lower-extremity wounds in Southeastern MichiganPritish K Tosh, Simon Agolory, Bethany L Strong, et al.
Open Forum Infectious Diseases|February 12, 2021
Validation of N95 Filtering Facepiece Respirator Decontamination Methods Available at a Large University HospitalKrista R Wigginton, Peter J Arts, Herek L Clack, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2022
Transmission of Carbapenem-Resistant Klebsiella pneumoniae in US HospitalsCourtney L Luterbach, Liang Chen, Lauren Komarow, et al.
Clinical Pharmacology and Therapeutics|June 17, 2025
Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of NephrotoxicityPatrick O Hanafin, Ramya Mahadevan, Gauri G Rao, et al.
JAMA|February 28, 2018
Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical TrialKeith S Kaye, Tanaya Bhowmick, Symeon Metallidis, et al.
Scientific Reports|July 29, 2025
A network analysis of carbapenem-resistant Klebsiella pneumoniae among healthcare facilitiesCourtney L Luterbach, Dana K Pasquale, Heather I Henderson, et al.
Microbiology Spectrum|May 23, 2023
Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumanniiHadas Kon, Amichay Hameir, Amir Nutman, et al.
Pageof 42